207 related articles for article (PubMed ID: 8639070)
1. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
[TBL] [Abstract][Full Text] [Related]
2. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
[TBL] [Abstract][Full Text] [Related]
3. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Yang TT; Wang L; Deng XY; Yu G
J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
[TBL] [Abstract][Full Text] [Related]
5. Treating fatigue.
Lapierre Y; Hum S
Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
[TBL] [Abstract][Full Text] [Related]
7. Treating fatigue in patients with MS: one step forward, one step back.
Schwid SR; Murray TJ
Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
[No Abstract] [Full Text] [Related]
8. Fatigue in MS.
Dulli D; Schutta H
Neurology; 1996 Nov; 47(5):1351. PubMed ID: 8909465
[No Abstract] [Full Text] [Related]
9. Fatigue in multiple sclerosis.
Krupp LB; Christodoulou C
Curr Neurol Neurosci Rep; 2001 May; 1(3):294-8. PubMed ID: 11898532
[TBL] [Abstract][Full Text] [Related]
10. Amantadine influences cognitive processing in patients with multiple sclerosis.
Sailer M; Heinze HJ; Schoenfeld MA; Hauser U; Smid HG
Pharmacopsychiatry; 2000 Jan; 33(1):28-37. PubMed ID: 10721881
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatments for fatigue associated with palliative care.
Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
[TBL] [Abstract][Full Text] [Related]
12. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
Weinshenker BG; Penman M; Bass B; Ebers GC; Rice GP
Neurology; 1992 Aug; 42(8):1468-71. PubMed ID: 1641137
[TBL] [Abstract][Full Text] [Related]
14. Amantadine treatment of fatigue associated with multiple sclerosis.
Cohen RA; Fisher M
Arch Neurol; 1989 Jun; 46(6):676-80. PubMed ID: 2730380
[TBL] [Abstract][Full Text] [Related]
15. Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.
Krupp LB; Sliwinski M; Masur DM; Friedberg F; Coyle PK
Arch Neurol; 1994 Jul; 51(7):705-10. PubMed ID: 8018045
[TBL] [Abstract][Full Text] [Related]
16. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
17. ['Fatigue' in multiple sclerosis].
Zimmermann C; Hohlfeld R
Nervenarzt; 1999 Jun; 70(6):566-74. PubMed ID: 10412704
[TBL] [Abstract][Full Text] [Related]
18. Fatigue associated with multiple sclerosis: diagnosis, impact and management.
Bakshi R
Mult Scler; 2003 Jun; 9(3):219-27. PubMed ID: 12814166
[TBL] [Abstract][Full Text] [Related]
19. Amantadine for fatigue in multiple sclerosis.
Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
